Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
|
|
SOLENO THERAPEUTICS INC (SLNO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/06/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 10.1% stake in SOLENO THERAPEUTICS, INC. |
| 10/05/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 4.6% stake in SOLENO THERAPEUTICS, INC. |
| 05/15/2023 |
SC 13G
| Vivo Opportunity Fund Holdings, L.P. reports a 20% stake in Soleno Therapeutics, Inc. |
| 04/05/2022 |
SC 13G
| HIRSCHMAN ORIN reports a 5.7% stake in SOLENO THERAPEUTICS, INC |
| 11/09/2020 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 7.2% stake in Soleno Therapeutics, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/16/2018 |
SC 13G
| 683 Capital Management, LLC reports a 7.3% stake in Soleno Therapeutics, Inc. |
| 12/26/2017 |
SC 13G
| Birchview Capital, LP reports a 6.2% stake in SOLENO THERAPEUTICS INC. |
| 12/26/2017 |
SC 13G
| FEINBERG LARRY N reports a 20% stake in Soleno Therapeutics, Inc. |
|
|